Hideki Koizumi
Publication Activity (10 Years)
Years Active: 2019-2024
Publications (10 Years): 13
Publications (10 Years): 13
University of the Ryukyus
Affiliation History
University of the Ryukyus
Oct 01 2017
Japan
Professor and Chairman :: Department of Ophthalmology
Publications
- Hideki Koizumi, Fumi Gomi, Akitaka Tsujikawa, Shigeru Honda, Ryusaburo Mori, Haruka Ochi, Keisuke Iwasaki, Annabelle Ayame Okada, null nullEfficacy, durability, and safety of faricimab up to every 16 weeks in patients with neovascular age-related macular degeneration: 2-year results from the Japan subgroup of the phase III TENAYA trial. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 262 (8) (2024)
- Hideki Koizumi, Fumi Gomi, Akitaka Tsujikawa, Shigeru Honda, Ryusaburo Mori, Haruka Ochi, Keisuke Iwasaki, Annabelle Ayame Okada, null nullEfficacy, durability, and safety of faricimab up to every 16 weeks in patients with neovascular age-related macular degeneration: 2-year results from the Japan subgroup of the phase III TENAYA trial. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 262 (8) (2024)
- Ayano Oshiro, Naoya Imanaga, Nobuhiro Terao, Hideki Koizumi
- Shota Sawaguchi, Nobuhiro Terao, Naoya Imanaga, Sorako Wakugawa, Yasunori Miyara, Ayano Oshiro, Marina Maehira, Yukihide Yamauchi, Hideki Koizumi
- Hideki Koizumi, Fumi Gomi, Akitaka Tsujikawa, Shigeru Honda, Ryusaburo Mori, Haruka Ochi, Keisuke Iwasaki, Annabelle Ayame Okada, null nullEfficacy, durability, and safety of faricimab up to every 16 weeks in patients with neovascular age-related macular degeneration: 2-year results from the Japan subgroup of the phase III TENAYA trial. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie (2024)
- Gemmy Cheung Chui Ming, Kunal K Dansingani, Hideki Koizumi, Timothy Y Y Lai, Sobha Sivaprasad, Camiel J F Boon, Elon H C Van Dijk, Jay Chhablani, Won Ki Lee, K Bailey Freund
- Hideki Koizumi, Fumi Gomi, Akitaka Tsujikawa, Shigeru Honda, Ryusaburo Mori, Haruka Ochi, Keisuke Iwasaki, Annabelle Ayame Okada, null nullEfficacy, durability, and safety of faricimab up to every 16 weeks in patients with neovascular age-related macular degeneration: 2-year results from the Japan subgroup of the phase III TENAYA trial. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 262 (8) (2024)
- Hideki Koizumi, Naoya Imanaga, Nobuhiro Terao
- Hideki Koizumi, Fumi Gomi, Akitaka Tsujikawa, Shigeru Honda, Ryusaburo Mori, Haruka Ochi, Keisuke Iwasaki, Annabelle Ayame Okada, null nullEfficacy, durability, and safety of faricimab up to every 16 weeks in patients with neovascular age-related macular degeneration: 2-year results from the Japan subgroup of the phase III TENAYA trial. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 262 (8) (2024)
- Takaaki Aichi, Nobuhiro Terao, Naoya Imanaga, Shota Sawaguchi, Sorako Wakugawa, Yasunori Miyara, Ayano Oshiro, Yukihide Yamauchi, Hideki Koizumi
- Tamaki Tamashiro, Koji Tanaka, Kanako Itagaki, Makiko Nakayama, Ichiro Maruko, Sorako Wakugawa, Nobuhiro Terao, Hajime Onoe, Yu Wakatsuki, Masashi Ogasawara, Yukinori Sugano, Akiko Yamamoto, Keiko Kataoka, Takahiko Izumi, Moeko Kawai, Ryusaburo Mori, Tetsuju Sekiryu, Annabelle A Okada, Tomohiro Iida, Hideki Koizumi, null null
- Hideki Koizumi, Akiko Yamamoto, Masashi Ogasawara, Ichiro Maruko, Taiji Hasegawa, Kanako Itagaki, Tetsuju Sekiryu, Annabelle A Okada, Tomohiro Iida
- Nobuhiro Terao, Hideki Koizumi, Kentaro Kojima, Natsuki Kusada, Kenji Nagata, Tetsuya Yamagishi, Kazuhito Yoneda, Kengo Yoshii, Shigeru Kinoshita, Chie Sotozono